Home » Breast Cancer Drug Exemestane May Increase Fracture Risk
Breast Cancer Drug Exemestane May Increase Fracture Risk
Women taking the anti-breast cancer drug exemestane should have regular bone monitoring to assess fracture risk because the treatment speeds up loss of bone density, a study suggests.
Nursing Times
Nursing Times
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May